Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
40.5M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
20M
-
Shares change
-
+71K
-
Total reported value, excl. options
-
$257M
-
Value change
-
+$495K
-
Number of buys
-
51
-
Number of sells
-
-68
-
Price
-
$12.77
Significant Holders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) as of Q3 2023
142 filings reported holding PAHC - PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share as of Q3 2023.
PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20M shares
of 40.5M outstanding shares and own 49.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.43M shares), VANGUARD GROUP INC (2.24M shares), PZENA INVESTMENT MANAGEMENT LLC (2.07M shares), BRANDES INVESTMENT PARTNERS, LP (1.87M shares), STATE STREET CORP (923K shares), DIMENSIONAL FUND ADVISORS LP (720K shares), HEARTLAND ADVISORS INC (704K shares), RENAISSANCE TECHNOLOGIES LLC (527K shares), MORGAN STANLEY (486K shares), and Bank of New York Mellon Corp (463K shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.